NYSE:NUVB | Cash Flow Statement | Nuvation Bio Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$62.84M
2026-03-31$5.4M$5.07M-$43.64M$44,000.00
2025-12-31-$36.59M-$29.73M$87.08M$8.06M
2025-09-30-$55.79M
2025-06-30-$59.01M
2025-03-31-$53.24M-$42.63M$54.18M$548,000.00
2024-12-31-$49.45M-$46.3M$51.77M-$900,000.00
2024-09-30-$41.21M
2024-06-30-$462.49M
2024-03-31-$14.79M-$15.7M$7.54M$21,000.00
2023-12-31-$13.79M-$15.03M$33.16M$120,000.00
2023-09-30-$19.65M
2023-06-30-$20.64M
2023-03-31-$21.73M-$19.33M-$52M$298,000.00
2022-12-31-$20.85M-$16.17M-$21.83M$407,000.00
2022-09-30-$27.2M
2022-06-30-$34.86M
2022-03-31-$21.29M-$24.93M-$5.55M$4.26M
2021-12-31-$25.13M-$23.48M-$189.26M$538,000.00
2021-09-30-$21.98M
2021-06-30-$19.33M
2021-03-31-$20.4M-$14.73M-$1.09M$624.96M
2020-12-31-$13.28M-$12.94M-$98.27M$132.64M
2020-09-30-$11.03M
2020-06-30-$8.6M
2020-03-31-$8.75M$8.72M$10.61M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$204.63M-$173.43M$99.52M$202.54M
2024-12-31-$567.94M-$130.41M$122.7M$331,000.00
2023-12-31-$75.8M-$68M$8.92M$628,000.00
2022-12-31-$104.2M-$96.11M$63.46M$1.33M
2021-12-31-$86.85M-$68.19M-$454.67M$625.53M
2020-12-31-$41.66M-$36.53M-$70.32M$133.14M